跳至主要内容
临床试验/EUCTR2015-005537-50-GB
EUCTR2015-005537-50-GB进行中(未招募)1 期

High Or Low Dose Syntocinon® for delay in labour: the HOLDS trial - HOLDS

Birmingham Women's Hospital0 个研究点目标入组 1,500 人开始时间: 2019年11月12日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Inclusion criteria - eligible women will include:
  • - nulliparous women who are able and willing to give informed consent
  • - singleton pregnancy of 37-41 weeks plus 6 days gestation
  • - confirmed delay in labour (using NICE intrapartum care guideline)
  • - ruptured membranes
  • - decision to prescribe syntocinon for augmentation of labour
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 100
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 1400
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Multiparous women
  • Nulliparous women who have reached full dilation of the cervix (10cm)
  • Nulliparpous women undergoing induction of labour
  • Nulliparpous women with a BMI >40 at booking
  • Nulliparpous women who have a multiple pregnancy
  • Nulliparpous women who have existing cardiac disease, bleeding disorders, diabetes (either pre-existing or gestational), scarred uterusprevious uterine surgery,
  • Nulliparpous women with significant antepartum haemorrhage
  • Women are under 16 years of age
  • Women who have a known contra-indication to oxytocin therapy as listed in the Summary of marketing Product Characteristics (SmPC)

研究者

发起方
Birmingham Women's Hospital

相似试验